(Q39247690)

English

Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

author name string

Eugen Musch

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Tamim Lutfi

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Petra von Stein

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Arezou Zargari

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Charlotte Admyre

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Mouhamad Malek

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Robert Löfberg

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Oliver D von Stein

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

1 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

283-292

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Recent Insights Into the Genetics of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Adherent-invasive Escherichia coli target the epithelial barrier

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Unravelling the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group).

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

A review of infliximab use in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Current and emerging drugs for the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Intestinal epithelial cells and their role in innate mucosal immunity

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Ileal pouch-anal anastomoses complications and function in 1005 patients

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Management of Crohn's disease in adults

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Inflammatory bowel disease: clinical aspects and established and evolving therapies

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Trends in the surgical treatment of ulcerative colitis over time: increased mortality and centralization of care

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.23019

21 January 2018

Identifiers

10.1002/IBD.23019

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39247690&oldid=1815876494"